Hong Kong Stock IPO: Yifei Technology initiates its public offering with an 18C mechanism, lacking cornerstone investors and a greenshoe option. As a leading player in the light industrial robotics sector in China, Yifei Technology is now open for subscriptions.
Financial Overview: Yifei Technology is projecting significant revenue growth from 2023 to 2025, with expected revenues of 200 million yuan, 270 million yuan, and 390 million yuan, respectively, translating to a compound annual growth rate (CAGR) of 38.8%. The surge in revenue is primarily driven by increased automation penetration in light industries and the broad deployment of the company’s comprehensive range of robotic products. Notably, sectors such as semiconductors and new energy are witnessing rapid breakthroughs.
During the same period, the number of direct sales customers is anticipated to grow from 158 to 507, while the net dollar retention rate for these customers is projected to rise from 75.4% to 115.2%. Additionally, expansion into overseas markets has begun to yield results, contributing to a diversified revenue structure.
The company’s revenue is categorized into two primary segments: robot bodies and robotic solutions. The revenue share from standardized robot bodies is expected to increase from 12.8% to 31.9%, with significant contributions from parallel and mobile robots. The market recognition of core hardware and software products continues to improve. Furthermore, the contribution of overseas revenue is expected to rise from 0.9% in 2023 to 9.8% by 2025, indicating steady progress in global expansion.
Gross Profit Margin: The overall gross profit margin for the company is anticipated to fluctuate, showing values of 18.3%, 26.5%, and 24.8% from 2023 to 2025. Notably, the gross margin for the robot body business is expected to improve significantly from 7.1% to 29.6%, reflecting the benefits of scale and technological premiums.
However, the gross margin is projected to slightly decline in 2025, primarily due to a higher proportion of lower-margin products like the Python and Camel series, as well as increased early-stage project completions in warehouse logistics automation.
Despite revenue growth, the company has been operating at a net loss, which is expected to widen significantly by 2025. The projected net losses for 2023, 2024, and 2025 are 110 million yuan, 70 million yuan, and 150 million yuan, respectively, with the 2025 loss increasing by 114.8% year-on-year. Adjusted net losses, excluding non-recurring items, are similarly projected to expand.
The primary driver behind the growing losses is the substantial investment in research and development, alongside increasing fixed expenditures. R&D spending is expected to rise by 83.1% in 2025, reaching 70.79 million yuan, comprising 18.3% of revenue. Non-recurring expenses related to stock options and listing costs have further exacerbated losses.
Inventory and Accounts Receivable: The company’s inventory balance is projected to grow significantly, reaching 200 million yuan, 190 million yuan, and 280 million yuan from 2023 to 2025. This increase is driven by proactive inventory management to meet order growth and instances where production outstrips sales, resulting in inventory accumulation.
In contrast, inventory impairment provisions are expected to decrease from 77.44 million yuan in 2023 to 33.57 million yuan in 2025, reducing the impact of impairment losses on current profitability.
However, accounts receivable is expected to grow rapidly, with trade receivables projected at 52.33 million yuan, 140 million yuan, and 170 million yuan over the same period. The annual compound growth rate is projected to reach 82.1%, significantly outpacing revenue growth. The days sales outstanding is also expected to double from 65 days in 2023 to 136 days in 2025, indicating a longer cash conversion cycle.
The increase in accounts receivable is primarily attributed to relaxed credit policies aimed at gaining market share, which has led to a decline in revenue quality and increased bad debt risks.
Cash Flow: Operating cash flow is projected to remain negative, with net outflows of -86.75 million yuan, -69.58 million yuan, and -180 million yuan from 2023 to 2025. The 2025 outflow is estimated to be 162.3% larger than 2024. The ongoing pressure on cash flow is largely due to high levels of accounts receivable and inventory, alongside continuous cash expenditures related to R&D and sales.
As of the end of 2025, the company’s cash and cash equivalents are projected to be 51.12 million yuan, indicating a pressing need for liquidity to support the IPO financing.
Valuation: The company is estimated to have a market value of 7.471 billion HKD. The valuation is based on the business model, financial indicators, and industry positioning, with comparable companies including TuoStar, AiFeiTe, and XinshiDa.
Investment Consideration: Yifei Technology’s strong growth trajectory, coupled with high gross margins from standardized robotic body sales, positions it favorably in a competitive market. Despite challenges related to cash flow and ongoing losses, its strategic investments and market positioning reflect robust long-term growth potential. The absence of cornerstone investors and a greenshoe option in this IPO may lead to increased volatility post-listing.
Investors should consider the potential for significant appreciation in the company’s valuation, particularly as it prepares to launch its first industrial-grade humanoid robot, “Hongjun,” in November 2025, marking its entry into the embodied intelligence sector.
Original article by NenPower, If reposted, please credit the source: https://nenpower.com/blog/wingtech-technology-launches-hong-kong-ipo-without-cornerstone-investors-or-greenshoe-option-leading-the-charge-in-chinas-light-industrial-robotics-sector/
